T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Tesla
TSLA
|
+$5.14B |
| 2 |
JPMorgan Chase
JPM
|
+$2.05B |
| 3 |
Atlassian
TEAM
|
+$2.04B |
| 4 |
NVIDIA
NVDA
|
+$1.97B |
| 5 |
Apple
AAPL
|
+$1.73B |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.32B |
| 2 |
Microsoft
MSFT
|
+$2.74B |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.74B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.9B |
| 5 |
Hilton Worldwide
HLT
|
+$1.79B |
Sector Composition
| 1 | Technology | 26.88% |
| 2 | Healthcare | 17.2% |
| 3 | Consumer Discretionary | 15.14% |
| 4 | Financials | 10.69% |
| 5 | Communication Services | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Emergent Biosolutions
EBS
$434M
| $10.3M | ﹤0.01% |
251,689
-20,384
| -7% | -$837K |
|
1352
PENN Entertainment
PENN
$2.86B
| $10.3M | ﹤0.01% |
242,389
-13,737
| -5% | -$583K |
|
1353
Immunocore
IMCR
$1.78B
| $10.3M | ﹤0.01% |
343,279
-36,612
| -10% | -$1.09M |
|
|
INFN
1354
DELISTED
Infinera Corporation Common Stock
INFN
| $10.3M | ﹤0.01% |
1,183,121
-1,806
| -0.2% | -$15.7K |
|
1355
Frontier Group Holdings
ULCC
$1.18B
| $10.2M | ﹤0.01% |
899,458
+27,115
| +3% | +$307K |
|
1356
Eventbrite
EB
$262M
| $10.2M | ﹤0.01% |
688,726
+29,793
| +5% | +$440K |
|
1357
Berkshire Hathaway Class A
BRK.A
$1.06T
| $10M | ﹤0.01% |
19
| – | – |
|
1358
Trinity Capital
TRIN
$1.13B
| $9.97M | ﹤0.01% |
516,409
-956
| -0.2% | -$18.5K |
|
|
AQUA
1359
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $9.81M | ﹤0.01% |
208,800
+176,138
| +539% | +$8.27M |
|
1360
Hydrofarm Holdings
HYFM
$15.3M
| $9.71M | ﹤0.01% |
64,060
+3,657
| +6% | +$554K |
|
1361
Consensus Cloud Solutions
CCSI
$524M
| $9.47M | ﹤0.01% |
157,517
+7,311
| +5% | +$440K |
|
1362
ProPetro Holding
PUMP
$484M
| $9.44M | ﹤0.01% |
+677,910
| New | +$9.44M |
|
1363
Schrodinger
SDGR
$1.37B
| $9.42M | ﹤0.01% |
276,090
+5,861
| +2% | +$200K |
|
1364
Bloom Energy
BE
$15.7B
| $9.34M | ﹤0.01% |
386,566
-161,717
| -29% | -$3.91M |
|
1365
SPDR Blackstone Senior Loan ETF
SRLN
$6.96B
| $9.33M | ﹤0.01% |
207,600
-279,500
| -57% | -$12.6M |
|
1366
Design Therapeutics
DSGN
$343M
| $9.27M | ﹤0.01% |
574,012
-213,653
| -27% | -$3.45M |
|
|
SMAR
1367
DELISTED
Smartsheet Inc.
SMAR
| $9.22M | ﹤0.01% |
168,263
-138,000
| -45% | -$7.56M |
|
|
CCXI
1368
DELISTED
ChemoCentryx, Inc.
CCXI
| $9.17M | ﹤0.01% |
365,634
-1,789
| -0.5% | -$44.8K |
|
1369
Chewy
CHWY
$14.4B
| $9.1M | ﹤0.01% |
223,083
-25,100
| -10% | -$1.02M |
|
1370
Silicon Laboratories
SLAB
$4.39B
| $9.07M | ﹤0.01% |
60,359
+1,592
| +3% | +$239K |
|
1371
Hayward Holdings
HAYW
$3.38B
| $8.94M | ﹤0.01% |
537,626
+517,493
| +2,570% | +$8.6M |
|
1372
Stoke Therapeutics
STOK
$1.29B
| $8.92M | ﹤0.01% |
423,863
-14,384
| -3% | -$303K |
|
1373
CureVac
CVAC
$1.2B
| $8.84M | ﹤0.01% |
450,642
-53,506
| -11% | -$1.05M |
|
1374
Envista
NVST
$3.49B
| $8.84M | ﹤0.01% |
181,401
+10,873
| +6% | +$530K |
|
1375
Genius Sports
GENI
$2.98B
| $8.77M | ﹤0.01% |
1,906,493
+732,935
| +62% | +$3.37M |
|